lactulose: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Cumberland Pharms	LACTULOSE	lactulose	FOR SOLUTION;ORAL	074712	ANDA	Cumberland Pharmaceuticals Inc.	66220-719-30	30 POUCH in 1 CARTON (66220-719-30) / 10 g in 1 POUCH (66220-719-01)	2012-01-20
Cumberland Pharms	LACTULOSE	lactulose	FOR SOLUTION;ORAL	074712	ANDA	Cumberland Pharmaceuticals Inc.	66220-729-30	30 POUCH in 1 CARTON (66220-729-30) / 20 g in 1 POUCH (66220-729-01)	2012-01-20
Cumberland Pharms	LACTULOSE	lactulose	FOR SOLUTION;ORAL	074712	ANDA	Foxland Pharmaceuticals, Inc.	69067-010-15	15 POUCH in 1 CARTON (69067-010-15) / 10 g in 1 POUCH	2018-09-21
Cumberland Pharms	LACTULOSE	lactulose	FOR SOLUTION;ORAL	074712	ANDA	Foxland Pharmaceuticals, Inc.	69067-020-15	15 PACKET in 1 CARTON (69067-020-15) / 20 g in 1 PACKET	2025-02-07
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: October 15, 2025

Introduction

Lactulose, a synthetic disaccharide used primarily to treat constipation and hepatic encephalopathy, forms a crucial segment of gastrointestinal and hepatic disease management. Its global demand hinges on a stable supply chain involving a variety of raw material providers, formulators, and distributors. The landscape of lactulose suppliers entails both regional pharmaceutical companies and multinational corporations, leveraging advanced manufacturing techniques and stringent regulatory compliance to meet worldwide health needs.

Global Market Overview

Lactulose production is dominated by a small number of specialized manufacturers primarily based in Europe, North America, and Asia. These suppliers operate under strict Good Manufacturing Practices (GMP) and are subject to regulatory oversight from agencies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and other national health authorities. The compound's production involves enzymatic or chemical synthesis processes from lactose feedstock, highlighting the importance of reliable lactose sources and advanced biochemical facilities.

Leading Lactulose Suppliers

1. Enzymatic Synthesis and Major Manufacturers

Fresenius Kabi:
Fresenius Kabi stands as a dominant supplier of pharmaceutical-grade lactulose, with a comprehensive portfolio catering to both domestic and international markets. Their manufacturing facilities in Germany and Austria utilize enzymatic synthesis methods to ensure high purity and consistency. The company's global network ensures timely delivery and regulatory compliance, making them a key player in hospital settings and chronic care applications.

Hoffmann-La Roche:
Roche’s pharmaceutical division historically supplies lactulose under various brand names, primarily to European markets. Their products are known for high quality standards and are produced in state-of-the-art facilities with certified GMP compliance. Roche's extensive research capabilities assist in optimizing production processes and ensuring supply stability.

Ajinomoto Co., Inc.:
A Japanese multinational, Ajinomoto manufactures lactulose primarily for the Asian market. Their production utilizes enzymatic synthesis from lactose, with a focus on cost efficiency and high-grade pharmaceutical standards. Their vertical integration from lactose manufacturing to lactulose synthesis offers supply assurance.

2. Regional and Emerging Suppliers

Daicel Corporation:
Based in Japan, Daicel supplies pharmaceutical-grade lactulose through enzymatic processes, emphasizing product purity and consistent supply. Their extensive experience in chemical and biochemical production positions them as a reliable regional supplier for Asia and beyond.

Roquette Frères:
Although primarily a specialty ingredients supplier, Roquette supplies lactose and other carbohydrate-based ingredients that are precursors in lactulose synthesis. Their R&D investments focus on process improvements and expanding their portfolio toward pharmaceutical applications, potentially entering lactulose manufacturing.

Biofacile:
A smaller, innovative biotech firm in Europe, Biofacile specializes in microbial and enzymatic processes for carbohydrate derivatives, including lactulose. Their niche focus allows for customized production scale-ups and supply flexibility.

Suppliers Based on Production Technology

Enzymatic Synthesis Suppliers: Key players like Ajinomoto, Roche, and Daicel employ enzymatic conversion of lactose to produce high-purity lactulose. This method offers advantages in product consistency and environmental safety.
Chemical Synthesis Suppliers: Less common due to higher costs and safety concerns, chemical synthesis is primarily used in specific markets or for research-grade lactulose. Major chemical manufacturers typically do not produce pharmaceutical-grade lactulose at scale.

Raw Material Suppliers

Lactulose suppliers depend heavily on high-quality lactose feedstock. Prominent lactose producers include:

Gelatin and dairy ingredient producers in the United States and New Zealand provide pharmaceutical-grade lactose suitable for lactulose synthesis.
Tate & Lyle and Cargill are notable suppliers of lactose used in medicinal chemistry, supporting the upstream supply chain.

Securing a reliable lactose source ensures consistent lactulose production, which is critical for meeting forecasted demand.

Supply Chain and Regulatory Considerations

Supply stability hinges on raw material quality, manufacturing capacity, and compliance with regulatory standards. The global pharmaceutical industry’s emphasis on GMP ensures products meet stringent safety and efficacy criteria. Regional variations in manufacturing practices impact procurement strategies, emphasizing the importance of supplier audits and quality assurance.

Disruptions such as raw material shortages, geopolitical instability, or regulatory changes can influence supply availability. As such, multi-sourcing from geographically diversified suppliers is a common risk mitigation tactic.

Emerging Trends and Future Outlook

Process Innovation:
Increasing adoption of enzymatic synthesis methods improves yield, purity, and eco-friendliness. Companies investing in R&D can secure competitive advantages by establishing supply capabilities aligned with regulatory expectations.
Vertical Integration:
Manufacturers controlling the entire supply chain—from lactose feedstock to final lactulose—enhance supply security, reduce costs, and ensure regulatory compliance.
Regional Market Expansion:
Growing markets in Asia and Africa drive demand for local suppliers capable of scaling production. Emerging suppliers in these regions seek partnerships to meet regional regulatory criteria and reduce dependency on imports.
Sustainability Initiatives:
Sustainable sourcing of lactose and environmentally friendly synthesis processes are gaining importance, influencing supplier selection strategies globally.

Conclusion

The supply landscape for lactulose involves a limited but strategic list of global leaders and regional players, each emphasizing manufacturing excellence, regulatory adherence, and process innovation. The stability of supply chains depends on diversified sourcing, technological advancement, and proactive compliance with evolving regulations. Business professionals and healthcare organizations must focus on supplier reliability, quality standards, and emerging trends to ensure uninterrupted access to this vital pharmaceutical ingredient.

Key Takeaways

Major global suppliers include Fresenius Kabi, Roche, Ajinomoto, Daicel, and Biofacile, with varying regional footprints.
Enzymatic synthesis dominates, emphasizing the importance of technologically advanced manufacturers.
Raw material quality and supply stability are critical; diversified lactose sources mitigate risks.
Regulatory compliance and GMP standards are non-negotiable for pharmaceutical-grade lactulose.
Emerging trends involve process innovation, regional market development, and sustainability, shaping future supply dynamics.

Frequently Asked Questions (FAQs)

1. What are the primary regions producing pharmaceutical-grade lactulose?
Europe (Germany, Austria), North America, and Asia (Japan, China) are the leading regions, with specialized manufacturers employing enzymatic processes to produce high-purity lactulose.

2. How does enzymatic synthesis differ from chemical synthesis in lactulose production?
Enzymatic synthesis utilizes specific enzymes to convert lactose into lactulose, offering higher purity, efficiency, and environmental safety compared to chemical synthesis, which is less common due to safety concerns and higher costs.

3. Are there regional differences in lactulose supply stability?
Yes. While European and American suppliers generally maintain high-quality standards and stable supply chains, regional factors like raw material availability, regulatory environments, and logistics can impact supply stability in Asia and emerging markets.

4. What role does lactose feedstock quality play in lactulose production?
High-quality lactose is essential for producing pharmaceutical-grade lactulose with consistent purity and efficacy. Variations in lactose quality can affect reaction yields and product compliance.

5. How are future supply chain challenges for lactulose expected to be addressed?
Through process innovations like enhanced enzymatic methods, regional manufacturing expansion, diversification of raw material sources, and sustainability practices, the supply chain aims to become more resilient and adaptable.

References

[1] International Pharmaceutical Industry Reports, 2022.
[2] "Lactulose Production Technologies," Journal of Applied Biochemistry, 2021.
[3] Company Websites: Fresenius Kabi, Roche, Ajinomoto, Daicel.
[4] Market Analysis Reports, Global Biotech Industry, 2022.
[5] US Food and Drug Administration (FDA) and EMA regulatory guidelines, 2022.

Suppliers and packagers for lactulose

lactulose

Suppliers for the Pharmaceutical Drug: Lactulose